Results 101 to 110 of about 881 (146)

Characterization of global cfDNA fragmentomics in Melanoma Patients

EJC Skin Cancer
J.L. Villanueva-Cañas, D. Rizo-Potau, A. Fornies, M. Aguilar, C. Sanchez-Cardenas, C. Carrera, S. Puig, J. Malvehy, J.A. Puig-Butille   +8 more
openaire   +1 more source

Cell-free DNA methylation and fragmentomics-based liquid biopsy for accurate esophageal cancer detection. [PDF]

BMC Cancer
Wang J, Zhang W, Li H, Wang Y, Qi J, Nie J.   +5 more
europepmc   +1 more source

Noninvasive detection and prognostic stratification of biliary tract cancer using cell-free DNA fragmentomics: a model development and validation study. [PDF]

Mol Biomed
Wang J, Ni X, Zheng Y, Wang S, Bao H, Fan K, Shen S, Zhu D, Xie Q, Bao H, Yang R, Wang C, Zheng B, Chang S, Xu X, Ni X, Suo T, Wu X, Liu H, Ma X, Liu H.   +20 more
europepmc   +1 more source

Advances and challenges in circulating tumor DNA-based early detection of lung cancer. [PDF]

Transl Cancer Res
Yoon JK, Park JY, Kim YW, Oh HJ, Kim YC.
europepmc   +1 more source

Mechanistic Modeling of cfDNA Fragmentome Dynamics Predicts Progression to Immunotherapy

BackgroundPlasma cell-free DNA (cfDNA) shows promise as predictive cancer biomarker, but mechanisms governing cfDNA production/fragmentation/elimination dynamics, and their relationships with tumor burden and disease progression, remain poorly understood.Methods We developed a mechanistic model jointly describing short (75-<580 bp) and long (≥580 ...
Nguyen Phuong, Linh, Fina, Frédéric, Greillier, Laurent, Tomasini, Pascale, Deville, Jean-Laurent, Boutonnet, Audrey, Ginot, Frédéric, Garcia, Jean-Charles, Salas, Sebastien, Benzekry, Sébastien   +9 more
openaire   +1 more source

Early Cancer Detection: What's Going on and What's Next. [PDF]

MedComm (2020)
Di Carlo E.
europepmc   +1 more source

DNAvi: integration, statistics, and visualization of cell-free DNA fragment traces. [PDF]

Bioinformatics
Hess A, Seelow D, Kretzmer H.
europepmc   +1 more source

Liquid biopsy in the clinical management of tumor of urinary system: current status and future developments. [PDF]

Cell Oncol (Dordr)
Xu R, Zhao Y, Su P, Li L, Liang H, Dong D, Wang K.   +6 more
europepmc   +1 more source

A Novel Cell-Free DNA Fragmentomic Assay and Its Application for Monitoring Disease Progression in Real Time for Stage IV Cancer Patients. [PDF]

Cancers (Basel)
Sinha SK, Brown H, Knopf K, Hall P, Shannon WD, Haack W.   +5 more
europepmc   +1 more source

Correction: Artificial intelligence in cancer epigenomics: a review on advances in pan-cancer detection and precision medicine. [PDF]

Epigenetics Chromatin
Sahoo K, Lingasamy P, Khatun M, Sudhakaran SL, Salumets A, Sundararajan V, Modhukur V.   +6 more
europepmc   +1 more source